QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
NASDAQ:TELA

TELA Bio Stock Forecast, Price & News

$15.82
+0.44 (+2.86 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$15.36
Now: $15.82
$16.19
50-Day Range
$13.12
MA: $14.33
$16.86
52-Week Range
$5.25
Now: $15.82
$23.55
Volume26,187 shs
Average Volume66,673 shs
Market Capitalization$228.03 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. The company provides a portfolio of OviTex Reinforced Tissue Matrix or OviTex products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix or OviTex PRS products to address the unmet needs in plastic and reconstructive surgery. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.43 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TELA
CUSIPN/A
CIKN/A
Phone484-320-2930

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.45 million
Book Value$2.71 per share

Profitability

Net Income$-22,420,000.00
Net Margins-152.45%

Miscellaneous

Employees89
Market Cap$228.03 million
Next Earnings Date12/16/2020 (Estimated)
OptionableNot Optionable
$15.82
+0.44 (+2.86 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TELA News and Ratings via Email

Sign-up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











TELA Bio (NASDAQ:TELA) Frequently Asked Questions

How has TELA Bio's stock price been impacted by COVID-19?

TELA Bio's stock was trading at $11.90 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TELA stock has increased by 32.9% and is now trading at $15.82.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of TELA Bio?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TELA Bio in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for TELA Bio
.

When is TELA Bio's next earnings date?

TELA Bio is scheduled to release its next quarterly earnings announcement on Wednesday, December 16th 2020.
View our earnings forecast for TELA Bio
.

How were TELA Bio's earnings last quarter?

TELA Bio (NASDAQ:TELA) released its earnings results on Wednesday, August, 12th. The company reported ($0.53) EPS for the quarter, beating the Zacks' consensus estimate of ($0.63) by $0.10. The firm earned $3.51 million during the quarter, compared to the consensus estimate of $2.20 million.
View TELA Bio's earnings history
.

What price target have analysts set for TELA?

5 analysts have issued 1 year target prices for TELA Bio's stock. Their forecasts range from $17.00 to $24.00. On average, they expect TELA Bio's stock price to reach $19.60 in the next twelve months. This suggests a possible upside of 23.9% from the stock's current price.
View analysts' price targets for TELA Bio
.

Are investors shorting TELA Bio?

TELA Bio saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 180,700 shares, a decline of 17.8% from the August 31st total of 219,700 shares. Based on an average trading volume of 108,300 shares, the days-to-cover ratio is presently 1.7 days. Approximately 2.0% of the company's stock are sold short.
View TELA Bio's Short Interest
.

Who are some of TELA Bio's key competitors?

What other stocks do shareholders of TELA Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TELA Bio investors own include Micron Technology (MU), Pfizer (PFE), Intel (INTC), Walt Disney (DIS), Crowdstrike (CRWD), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Alteryx (AYX) and Cisco Systems (CSCO).

Who are TELA Bio's key executives?

TELA Bio's management team includes the following people:
  • Mr. Antony Koblish, Co-founder, Pres, CEO & Director (Age 54, Pay $559.54k)
  • Dr. Maarten Persenaire, Co-Founder & Chief Medical Officer (Age 63, Pay $408.43k)
  • Dr. E. Skott Greenhalgh Ph.D., Chief Technology Officer (Age 53, Pay $402.73k)
  • Ms. Nora E. Brennan, Chief Financial Officer (Age 51)
  • Mr. Michael Leonard, VP of Operations

When did TELA Bio IPO?

(TELA) raised $60 million in an IPO on Friday, November 8th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is TELA Bio's stock symbol?

TELA Bio trades on the NASDAQ under the ticker symbol "TELA."

Who are TELA Bio's major shareholders?

TELA Bio's stock is owned by a number of retail and institutional investors. Top institutional investors include Essex Woodlands Management Inc. (12.20%), RTW Investments LP (11.96%), Alyeska Investment Group L.P. (6.35%), Silvercrest Asset Management Group LLC (2.85%), Sanders Morris Harris LLC (2.32%) and Opaleye Management Inc. (2.19%). Company insiders that own TELA Bio stock include Matt Zuga and Orbimed Advisors Llc.
View institutional ownership trends for TELA Bio
.

Which major investors are buying TELA Bio stock?

TELA stock was purchased by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Silvercrest Asset Management Group LLC, Essex Woodlands Management Inc., Sanders Morris Harris LLC, RTW Investments LP, Luminus Management LLC, Opaleye Management Inc., and Schonfeld Strategic Advisors LLC. Company insiders that have bought TELA Bio stock in the last two years include Matt Zuga, and Orbimed Advisors Llc.
View insider buying and selling activity for TELA Bio
.

How do I buy shares of TELA Bio?

Shares of TELA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is TELA Bio's stock price today?

One share of TELA stock can currently be purchased for approximately $15.82.

How big of a company is TELA Bio?

TELA Bio has a market capitalization of $228.03 million and generates $15.45 million in revenue each year. The company earns $-22,420,000.00 in net income (profit) each year or ($17.10) on an earnings per share basis. TELA Bio employs 89 workers across the globe.

What is TELA Bio's official website?

The official website for TELA Bio is www.telabio.com.

How can I contact TELA Bio?

TELA Bio's mailing address is 1 GREAT VALLEY PARKWAY SUITE 24, MALVERN PA, 19355. The company can be reached via phone at 484-320-2930 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.